INSIGHTS ON CLINICAL TRIAL DESIGN

• Leveraging Biomarkers In Early PK/PD Studies

  Integrating biomarkers into early clinical studies is crucial to determine whether a new therapy engages its biological target, triggers the intended PD effects, and shows early signs of efficacy.

• Developing Community-Based And Trial-Naïve Sites: The Real ROI

  Trial-naïve sites, when supported with infrastructure, training, and network integration, represent a critical yet underused opportunity to expand patient access and accelerate recruitment.

• How Home Trial Visits Support Sites And Patients

  By reaching into the heart of communities, Home Trial Support plays an invaluable role in driving the development of lifesaving, representative, medicines and therapies.

• Flexible By Design: Support For Early-Phase Oncology Trial

  Shifting cohorts, doses, and protocols challenge early-phase oncology trials. Learn how adaptable technology keeps studies on track.

• GSK And Medable Discuss The Next Phase Of DCTs

  3/10/2025

  GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.

• The Evolving Role Of Healthy Participants In Early Immuno-Oncology Trials

  11/21/2025

  Explore how leveraging healthy participants, advanced immune-challenge models, and high-dimensional biomarker analyses can transform early immuno-oncology development.

• How AI Is Reshaping Trial Design, Execution, And Disclosure

  9/25/2025

  AI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.

• Why Benchmarking Inflammatory Models Matters: What Early Human Data Tells Us

  7/6/2026

  Benchmarking immune challenge models clarifies early pharmacodynamic signals, helping teams distinguish true target engagement from variability, prioritize endpoints, and make confident decisions.

• Challenges, Opportunities For Recruitment In The Digital Age

  10/20/2025

  Health literacy gaps and online misinformation hinder clinical trial recruitment. Meeting patients where they are — digitally and educationally — can improve engagement and enrollment success.